Rhythm Pharmaceuticals, Inc.
RYTM
$50.97
$0.731.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.88% | -35.39% | 77.18% | -239.57% | 5.73% |
| Total Depreciation and Amortization | -0.52% | -1.28% | -3.70% | -2.88% | -5.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.59% | 170.71% | -95.18% | 3,402.46% | -81.78% |
| Change in Net Operating Assets | 117.15% | 319.06% | 1.92% | -124.56% | 664.58% |
| Cash from Operations | 25.26% | 13.28% | 28.64% | -38.66% | -0.45% |
| Capital Expenditure | -- | -- | -- | -- | 200.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 123.30% | -960.71% | -128.49% | 32.74% | 123.84% |
| Cash from Investing | 123.30% | -960.71% | -128.49% | 32.73% | 123.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 622.99% | 315.69% | -80.05% | 40.60% | -90.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.15% | -156.28% | 312.97% | -8.12% | -111.59% |
| Cash from Financing | 1,438.04% | -98.30% | 3,345.18% | 75.11% | -96.68% |
| Foreign Exchange rate Adjustments | 262.02% | -100.33% | -323.94% | 63.02% | -349.35% |
| Miscellaneous Cash Flow Adjustments | 200.00% | -- | -- | -- | -- |
| Net Change in Cash | 136.46% | -205.46% | 1,759.87% | -44.53% | 91.17% |
